Company Search:
Advanced Search
Sponsored Links
Veloxis Pharmaceuticals A/S Company Snapshot
Veloxis Pharmaceuticals A/S operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Veloxis Pharmaceuticals A/S with three other miscellaneous service companies in Europe: Proteome Sciences PLC of the United Kingdom (2015 sales of £1.88 million [US$2.31 million] ), Active Biotech AB of Sweden (16.28 million Swedish Kronor [US$1.84 million] of which 63% was Rent and Services), and Bioinvent International AB which is also based in Sweden (15.93 million Swedish Kronor [US$1.80 million] of which 100% was Drug Development).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Veloxis Pharmaceuticals A/S
  Stock Performance Chart for Veloxis Pharmaceuticals A/S
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 1.30
(Figures in Danish Kroner)
1 Week -1.5%   13 Weeks 6.6%  
4 Weeks 12.1%   52 Weeks -15.6%  
Veloxis Pharmaceuticals A/S Key Data:
  Ticker: VELO Country: Denmark
  Exchanges: CPH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 14,150,000
(Year Ending Jan 2016).
Employees: 38
  Currency: Danish Kroner Market Cap: 2,208,796,045
  Fiscal Yr Ends: December Shares Outstanding: 1,699,073,881
  Share Type: Stammaktie Closely Held Shares: 725,504,547
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.